# Author Correction: ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer

**Authors:** Christopher W Schultz, Yang Zhang, Rajaa Elmeskini, Astrid Zimmermann, Haiqing Fu, Yasuhisa Murai, Darawalee Wangsa, Suresh Kumar, Nobuyuki Takahashi, Devon Atkinson, Liton Kumar Saha, Chien-Fei Lee, Brian Elenbaas, Parth Desai, Robin Sebastian, Ajit Kumar Sharma, Melissa Abel, Brett Schroeder, Manan Krishnamurthy, Laurel L Bassel, Rajesh Kumar, Nitin Roper, Mirit Aladjem, Frank T Zenke, Zoe Weaver Ohler, Yves Pommier, Anish Thomas

PMC · DOI: 10.1038/s44321-024-00029-x · EMBO Molecular Medicine · 2024-02-16

## Full-text entities

- **Genes:** ATR (ATR checkpoint kinase) [NCBI Gene 545] {aka FCTCS, FRP1, MEC1, SCKL, SCKL1}
- **Diseases:** small-cell lung cancer (MESH:D055752)
- **Chemicals:** lurbinectedin (MESH:C568606)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10940574/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC10940574/full.md

---
Source: https://tomesphere.com/paper/PMC10940574